The visionaries driving Tolion Health
Martin Tolar, MD, PhD
Founder & Director
Martin Tolar, MD, PhD
During his academic career, Dr. Tolar served as an Assistant Professor in the Department of Neurology at Yale University School of Medicine, where he focused on movement disorders. Dr. Tolar trained in Neurology at the Boston Medical Center, received a Ph.D. in Neuroscience for his work on the role of apolipoprotein E in pathogenesis of Alzheimer’s disease, and published many scientific publications in the areas of neuroscience and neurodegenerative disorders. Dr. Tolar received his M.D. from Charles University in Prague, where, as a medical student, he helped organize and lead the Velvet Revolution that toppled the communist regime in the former Czechoslovakia in November 1989.
In 2021, Dr. Tolar founded the International Neurodegenerative Disorders Research Center, INDRC, a global institute applying artificial intelligence and machine learning solutions to identify and validate therapeutic interventions for Alzheimer’s disease and other neurodegenerative disorders. He serves as the Chairman of the INDRC Executive Board. Dr. Tolar also serves on business and scientific boards including the Alzheimer’s Drug Discovery Foundation, the Alzheimer Foundation, the CERGE-EI Foundation, and Advance Healthcare Management Institute.
In 2024, Dr. Tolar received the Eliška and Zdeněk Strmiska Award from the Alzheimer’s Foundation for significant contribution towards the research and treatment of Alzheimer´s disease and donated the cash prize to the INDRC institute. In 2021, Dr. Tolar received the Czech Laurels Award from the Czech Chamber of Commerce in recognition of his leadership in Alzheimer disease therapeutics, as well as clinical, scientific, and business projects in the Czech Republic. The Czech Chamber of Commerce is the largest and the most representative business association in the Czech Republic. Dr. Tolar was recognized as one of the Top 100 Most Influential People in the world of drug development and manufacture by The Medicine Maker Magazine’s Power Lists for 2016, 2017, 2018 and 2019.
Ken Mace, MBA
US Finance & Legal
Kenneth Mace, MBA
Mr. Ken Mace brings to Alzheon more than 20 years of senior finance and operations leadership in leading, building and advising biopharmaceutical companies; with extensive experience with developing business plans, financing strategies and financial modeling. Previously, Mr. Mace served as the Vice President of Finance, New Ventures at Flagship Pioneering, a venture capital firm that creates and grows first-in-category life science companies, where he supported 20+ new venture entities. Before Flagship Pioneering, Mr. Mace was Vice Director and Senior Project Manager, Group Planning and Special Projects, with F. Hoffman-La Roche Ltd., where he provided financial analysis in support of long-range business planning. Earlier, Mr. Mace was Vice President of Finance and Global Operations at mtm laboratories AG, an in-vitro diagnostics company. In this role, he was responsible for finance and sales operations and was the finance lead for the $230 million acquisition by Roche Diagnostics. Mr. Mace also held positions of increasing responsibility with life science companies ViaCell, Inc., Cytyc Corporation and Boston Scientific Corporation.
Mr. Mace earned his MBA from Babson College and BS in Accounting and Finance from Roger Williams University.
Ing. Jaroslav Lískovec
Chief Executive Officer
Ing. Jaroslav Lískovec
Jaroslav Lískovec brings 15+ years of leadership experience. His backround is primarily entrepreneurship in the technology sector. He has also implemented strategic projects for the government of the Czech Republic such as the creation of the largest strategic industrial zone Triangle, the establishment of a new state-owned enterprise NAKIT focused on technologies for eGovernment and critical communication infrastructure of the state.
He also created the National Centre for Industry 4.0 and was an advisor to the Minister of Industry and Trade on technology, innovation and economic strategy. In the area of startups, he is responsible for the commercialisation and technology transfer of research at CTU – the oldest technical university in Europe – and is co-founder of CTU’s first employee spin-off TRIX Connections.
doc. Ing. Petr Kadera, PhD
Chief Technical Officer
doc. Ing. Petr Kadera, PhD
Petr Kadera brings over 15 years of experience in artificial intelligence for industrial applications. He leads a research group at the Czech Institute of Informatics, Robotics, and Cybernetics at CTU in Prague, focusing on intelligent systems for industry and smart grids. His work encompasses developing industrial multi-agent systems, with extensive collaborations with companies such as Skoda-Auto, Rockwell Automation, and Airbus. He has also contributed to significant European projects like DIGICOR, aiming to enhance collaboration across manufacturing industries.
In the commercial sphere, Petr Kadera is a partner and CTO in several spin-offs and startups, where he drives the development of AI-based automation solutions. His leadership in these ventures showcases his dedication to applying cutting-edge research in real-world industrial scenarios. His academic contributions include over 50 publications, patents, and involvement in organizing international conferences on multi-agent systems.
Ondřej Lerch, MD, PhD
Chief Medical Officer
Ondřej Lerch, MD, PhD
Aleš Navrátil
Chief Operations Officer
Aleš Navrátil
Aleš Navrátil brings over 20 years of leadership and management experience, with a strong focus on service delivery, customer service, and large-scale project management. His expertise includes the implementation of ERP solutions, integration with other enterprise systems, and the establishment of project management offices. Aleš is also highly experienced in company transformations, where he has designed and optimized management systems and processes to drive operational efficiency.
In the realm of operations, he possesses extensive knowledge of processes, IT technologies, and security, ensuring seamless and secure business operations. Aleš collaborated on the creation of NAKIT, a state-owned enterprise focused on technology for eGovernment and critical infrastructure. He has also held key leadership roles, such as Chief Operations Officer and Quality Management Representative at CertiCon, a leading technology company specializing in software development and testing.
Prior to his roles at NAKIT and CertiCon, Aleš gained 10 years of experience in the retail sector and before that, he worked in IT services and for a state-owned company managing state claims and assets.
Ing. Milan Drahoňovský, PhD
Chief Financial Officer
Ing. Milan Drahoňovskýk, PhD
Milan Drahoňovský currently works with a multinational company specializing in the transportation, maintenance, and repair of railway complexes. Previously, he eagerly embraced the opportunity to contribute to the official production of currency, IDs, passports, driving licenses, and excise stamps for alcohol and tobacco at the State Printing of Securities in Prague. In this role, he managed economic operations, purchasing, warehousing, and related functions.
Mr. Drahoňovský also served as Deputy Director at one of the largest research institutions in the country, overseeing economics, purchasing, facility management, maintenance, and the grant office. Earlier in his career, he joined Deloitte, focusing on economic, process, and analytical topics within the public administration sector, leading projects for the Ministry of Finance, municipal administrations, universities, hospitals, and research institutions.
He began his career in 2001, collaborating with a German consulting firm in the energy sector, where he led projects across Germany, the Czech Republic, Slovakia, and Romania, addressing restructuring, strategic purchasing, controlling, and other areas.
Ing. Petr Zmátlo
Chief Business Officer
Ing. Petr Zmátlo
During his time at Apple company, Petr drove significant sales growth in Central and Eastern Europe. More recently, in field of manufacturing plants technology area, he has enhanced the market presence of European companies by restructuring sales and channels across 14 countries.